Part Details | DRONABINOL CAPSULES
6505-01-650-3492
Alternate Parts: NDC00051002221, NDC00051-0022-21, NDC00591359260, NDC00591-3592-60, 1390073, 6505NCM152493, NDC49884086802, NDC49884-0868-02, 6505-01-650-3492, 01-650-3492, 6505016503492, 016503492
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-650-3492
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00051-0022-21 | 6XMS3 | ABBVIE US LLC |
| NDC00591-3592-60 | 6LMB8 | ACTAVIS PHARMA, INC. |
| 1390073 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM152493 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC49884-0868-02 | 0VZ14 | PAR PHARMACEUTICAL, INC.DBA PAR PHARMACEUTICAL |
Technical Data | NSN 6505-01-650-3492
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | DRONABINOL 5 MG CAPSULE 60S; NON-USP; FOR ORAL ADMINISTRATION; DEA SCHEDULE III CONTROLLED SUBSTANCE; EACH CAPSULE CONTAINS: DRONABINOL 5 MG; STORE IN A COOL ENVIRONMENT BETWEEN 8 AND 15 C (46 AND 59 F) AND ALTERNATIVELY COULD BE STORED IN A REFRIGERATOR; PROTECT FROM FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | MARINOL 5 MG CAPSULE 60S |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE III |